 | Up a level |
Li, Xiaoxin; Zhu, Qi; Egger, Anna; Chang, Liu; Wolf, Sebastian; Song, Yanping; Zhang, Junjun; Dong, Fangtian; Xu, Xun; Weisberger, Annemarie (2021). Two different treatment regimens of ranibizumab 0.5 mg for neovascular age-related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study. Acta ophthalmologica, 99(3), e336-e345. Wiley 10.1111/aos.14588
Li, Xiaoxin; Dai, Hong; Li, Xiaorong; Han, Mei; Li, Jun; Suhner, Andrea; Lin, Renxin; Wolf, Sebastian (2019). Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study. Graefe's archive for clinical and experimental ophthalmology, 257(3), pp. 529-541. Springer 10.1007/s00417-018-04213-x
